版塊導(dǎo)航: 正在加載中...

應(yīng)《網(wǎng)絡(luò)安全法》要求，自2017年10月1日起，未進(jìn)行實(shí)名認(rèn)證將不得使用互聯(lián)網(wǎng)跟帖服務(wù)。為保障您的帳號(hào)能夠正常使用，請(qǐng)盡快對(duì)帳號(hào)進(jìn)行手機(jī)號(hào)驗(yàn)證，感謝您的理解與支持！

24小時(shí)熱門版塊排行榜

返回列表

cainiaodui

新蟲 (小有名氣)

應(yīng)助: 0 (幼兒園)
金幣: 1762.1
散金: 6
帖子: 235
在線: 159.7小時(shí)
蟲號(hào): 2608180
注冊(cè): 2013-08-20
專業(yè): 中醫(yī)內(nèi)科

[求助] 翻譯求助

Chemotherapy is beneficial for palliation in patients with locallyadvanced and metastatic disease.Adjuvant chemotherapy is generally indicated for patients
with resected stages IIA through IIIA NSCLC.Although chemotherapy is appropriate for many patients with lung cancer, there is a sense that
the use of traditional chemotherapeutic agents has reached a therapeutic plateau. Increasedunderstanding of cancer biology has revealed numerous potential therapeutic strategies,including targeting EGFR and other signal transduction and angiogenesis pathways.

回復(fù)此樓

» 猜你喜歡

327求調(diào)劑已經(jīng)有5人回復(fù)
361求調(diào)劑已經(jīng)有3人回復(fù)
一志愿中南大學(xué)化學(xué)學(xué)碩0703總分337求調(diào)劑已經(jīng)有5人回復(fù)
一志愿北京化工大學(xué) 070300 學(xué)碩 336分求調(diào)劑已經(jīng)有6人回復(fù)
材料專業(yè)求調(diào)劑已經(jīng)有10人回復(fù)
341求調(diào)劑(一志愿湖南大學(xué)070300) 已經(jīng)有5人回復(fù)
0854 考研調(diào)劑招生了！AI 方向已經(jīng)有15人回復(fù)
384求調(diào)劑已經(jīng)有6人回復(fù)
生物學(xué)學(xué)碩求調(diào)劑已經(jīng)有4人回復(fù)
081700 調(diào)劑 267分已經(jīng)有6人回復(fù)

1樓 2014-05-19 20:58:37

已閱回復(fù)此樓關(guān)注TA 給TA發(fā)消息送TA紅花 TA的回帖

晨曦?M荷

銅蟲 (小有名氣)

應(yīng)助: 0 (幼兒園)
金幣: 105.7
散金: 7
帖子: 54
在線: 17.1小時(shí)
蟲號(hào): 3215835
注冊(cè): 2014-05-18
專業(yè): 原子和分子物理

【答案】應(yīng)助回帖

★ ★ ★
RXMCDM: 金幣+1 2014-05-19 22:17:27
cainiaodui(RXMCDM代發(fā)): 金幣+2, 多謝應(yīng)助！ 2014-06-15 00:55:45

???W???????p?p????????[?????????[???D???????????檔?o??????W????????m????г?IIA?cIIIA???С?????????????m??f???W?????????????????????m??????????^?c?J????y????W????????_?????????i?A?Ρ??S?????Y????W??l????д???????????????l?F?????а?????????????L???????w????????????????????????
????L???????????????

贊一下

回復(fù)此樓

2樓2014-05-19 22:15:44